radiobiology

You have access
Dosimetry for Radiopharmaceutical Therapy: The European Perspective
Michael Lassmann, Uta Eberlein, Jonathan Gear, Mark Konijnenberg and Jolanta Kunikowska

Journal of Nuclear Medicine December 1, 2021, 62 (Supplement 3) 73S-79S; DOI: https://doi.org/10.2967/jnumed.121.262754
You have access
Radiation Dosimetry in ¹⁷⁷Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
Price A. Jackson, Michael S. Hofman, Rodney J. Hicks, Mark Scalzo and John Violet

Journal of Nuclear Medicine July 1, 2020, 61 (7) 1030-1036; DOI: https://doi.org/10.2967/jnumed.119.233411
You have access
Prediction of Tumor Control in ⁹⁰Y Radioembolization by Logit Models with PET/CT-Based Dose Metrics
Yuni K. Dewaraja, Theresa Devasia, Ravi K. Kaza, Justin K. Mikell, Dawn Owen, Peter L. Roberson and Matthew J. Schipper

Journal of Nuclear Medicine January 1, 2020, 61 (1) 104-111; DOI: https://doi.org/10.2967/jnumed.119.226472
You have access
The Relevance of Dosimetry in Precision Medicine
Michael Lassmann and Uta Eberlein

Journal of Nuclear Medicine October 1, 2018, 59 (10) 1494-1499; DOI: https://doi.org/10.2967/jnumed.117.206649
You have access
First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using ⁸⁹Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A. Ulaner, Serge K. Lyashchenko, Christopher Riedl, Shutian Ruan, Pat B. Zanzonico, Diana Lake, Komal Jhaveri, Brian Zeglis, Jason S. Lewis and Joseph A. O’Donoghue

Journal of Nuclear Medicine June 1, 2018, 59 (6) 900-906; DOI: https://doi.org/10.2967/jnumed.117.202010
You have access
Individualized Dosimetry for Theranostics: Necessary, Nice to Have, or Counterproductive?
Uta Eberlein, Marta Cremonesi and Michael Lassmann

Journal of Nuclear Medicine September 1, 2017, 58 (Supplement 2) 97S-103S; DOI: https://doi.org/10.2967/jnumed.116.186841

Main menu

User menu

Search

radiobiology